Please click here to obtain permission to reproduce this image.
Click on image to view larger version.
Figure 1 Impact of Candesartan on Hyperkalemia Risk in CHARM-Overall, by Subgroups
Subgroups assigned according to patient characteristics at baseline. Baseline values for serum potassium and creatinine were available only for the subset of patients enrolled in North America. ACE = angiotensin-converting enzyme.
|
